Talk:Guselkumab
Jump to navigation
Jump to search
| This is the talk page for discussing improvements to the Guselkumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Guselkumab.
|
What side effects
Since plaque psoriasis says the systemic agents have high toxicity we could usefully say what the (3) phase III studies have shown. - Rod57 (talk) 10:27, 20 July 2017 (UTC)
Article expansion
Greetings editors, My apologies for inappropriate source use. I am working on expanding this article for a class, so I appreciate any suggestions you have on improving content I contribute. - jcva2017